Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

Windsor resident beating the odds following devastating diagnosis and treatment for usually deadly form of pancreatic cancer.

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

A study has found that people exercise regularly, quit smoking, and practice five other health strategies can improve their chances of living longer after cancer.

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...